Recent developments in techniques for rapid and efficient oligonucleotide synthesis and molecular biology technology have expanded the market for manufacturers and service providers in the field. Liquid chromatography coupled with mass spectrometry (LC-MS) workflows play a critically important role.
At Chiesi Group’s Chippenham laboratory in the UK, Waters’ UPLC systems with mass detection and informatics keep the team at the forefront of inhalation drug delivery products.
In Japan, Professor Masanori Kataoka finds that the ACQUITY QDa Mass Detector is suitable for the synthesis and analysis of oligonucleotides – and sees ways to expand its use.
We discuss analytical options using LC and GC with MS/MS to detect the pesticide fipronil in eggs for food safety testing.
Waters Corporation and PRIMORIS Belgium… a reliable relationship It makes sense, doesn’t it? No one likes being let down; disappointed. Especially when the consequences are significant. Take, for example, a specialized food testing laboratory –… Read more >
How WEQAS is expanding their capabilities with a Waters Xevo TQ-XS Many laboratories participate in external quality assurance proficiency programs, which enable them to compare their results to those of other laboratories. This is essential… Read more >
“One of the important reasons that we use Waters LC-MS instruments is that beyond the quality of the products, Waters delivers a high degree of technical training. This provides us with the knowledge and confidence that we can solve our complex research questions.” comments Triskelion’s Richard Bas.
Choosing the right technology is crucial – so it’s great when innovation makes the decision clear-cut. With Gerard Rosse, Associate Director, Structure Guided Chemistry at Dart NeuroScience.
With access to multiple mass spectrometry systems of varying degrees of sophistication, Davy Guillarme (University of Geneva, Switzerland) wasn’t actively looking for new mass detection solutions. Nevertheless, the Waters ACQUITY QDa mass detector caught his eye.
At Reach Separations, they’re putting robust detection on the front lines of method development and mass confirmation.
